The predictive value of hepatic artery perfusion scintigraphy.
A case in which hepatic artery perfusion scintigraphy (HAPS) correctly predicted the outcome of chemotherapy in a patient with metastatic liver disease is presented. In spite of angiography showing "proper" position of the Infusaid catheter, HAPS showed preferential perfusion to the right lobe of the liver. Computed tomography pre- and postchemotherapy showed a changing pattern of the metastatic foci correlating with the perfusion demonstrated by HAPS.
Borzutzky
C A
CA
Turbiner
E H
EH
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D005500:Follow-Up Studies; D006499:Hepatic Artery / Q000000981:diagnostic imaging*; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D011379:Prognosis; D011877:Radionuclide Imaging; D013668:Technetium Tc 99m Aggregated Albumin
D013668:Technetium Tc 99m Aggregated Albumin; D005467:Floxuridine